{"title":"NM_007294.3:c.446A\u003eC AND Breast-ovarian cancer, familial 1","submission_id":"500037.2012-07-24","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000053775","review_status":"no assertion criteria provided","variation_archive_id":"VCV000037594","date_created":"2012-11-07","version":"3","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2008-09-04","assertion_type":"variation to disease","internal_id":"89390","clinical_assertion_observation_ids":["SCV000053775.0"],"id":"SCV000053775","local_key":"SCRP_var_219","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000031175","record_status":"current","submitter_id":"500037"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Insufficient or conflicting evidence\"}"],"clinical_assertion_trait_set_id":"SCV000274232","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2016-05-27","version":"2","trait_set_id":"13598","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-05-24","assertion_type":"variation to disease","internal_id":"510686","clinical_assertion_observation_ids":["SCV000274232.0"],"id":"SCV000274232","local_key":"a31329","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000219296","record_status":"current","submitter_id":"61756"}
{"submission_id":"500105.2018-11-14","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000895101","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"practice guideline\",\"ID\":[{\"$\":\"25741868\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2015.30\",\"@Source\":\"DOI\"}]}}","date_created":"2019-03-28","version":"1","submission_names":["SUB4786732"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-10-31","assertion_type":"variation to disease","internal_id":"1751540","clinical_assertion_observation_ids":["SCV000895101.0"],"id":"SCV000895101","local_key":":Chr.17_41251893_41251893_T_G|OMIM:114480;604370;614320;617883","interpretation_description":"Uncertain significance","variation_id":"37594","record_status":"current","submitter_id":"500105"}
{"submission_id":"505849.2018-11-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000910906","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2019-05-17","version":"1","trait_set_id":"13598","submission_names":["SUB4721021"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-04-19","assertion_type":"variation to disease","internal_id":"1778861","clinical_assertion_observation_ids":["SCV000910906.0"],"id":"SCV000910906","local_key":"Db4KrQBSZeoE7-orUyypkaRSy9Lm52xvIWbvYpjplzM|MedGen:C0027672","interpretation_description":"Likely benign","variation_id":"37594","rcv_accession_id":"RCV000219296","record_status":"current","submitter_id":"505849"}
{"submission_id":"500031.2019-03-28","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces glutamic acid with alanine at codon 149 of the BRCA1 protein (p.Glu149Ala). The glutamic acid residue is moderately conserved and there is a moderate physicochemical difference between glutamic acid and alanine. This variant is present in population databases (rs397507233, ExAC 0.07%). This variant has been reported in individuals affected with breast cancer (PMID: 22116506, 27257965) and stomach cancer (PMID: 26689913). ClinVar contains an entry for this variant (Variation ID: 37594). Experimental studies have shown that this missense change does not impact BRCA1 homology-directed repair activity (PMID: 26689913). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.\"}"],"clinical_assertion_trait_set_id":"SCV000549301","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26689913\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22116506\",\"@Source\":\"PubMed\"}}]}}","date_created":"2017-04-13","version":"5","trait_set_id":"7920","submission_names":["SUB5371970"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-12-19","assertion_type":"variation to disease","internal_id":"1062197","clinical_assertion_observation_ids":["SCV000549301.0"],"id":"SCV000549301","local_key":"676082|MedGen:C0677776","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000458634","record_status":"current","submitter_id":"500031"}
{"submission_id":"26957.2019-01-29","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is denoted BRCA1 c.446A\u003eC at the cDNA level, p.Glu149Ala (E149A) at the protein level, and results in the change of a Glutamic Acid to an Alanine (GAA\u003eGCA). Using alternate nomenclature, this variant would be defined as BRCA1 565A\u003eC. This variant was observed in several individuals with breast cancer and in one individual with gastric cancer (Zhang 2012, Lu 2015, Zhong 2016, Wei 2018). Functional analysis of this variant showed no significant difference as compared to wild type in a homologous directed repair assay (Lu 2015). BRCA1 Glu149Ala was observed at an allele frequency of 0.06% (12/18870) in individuals of East Asian ancestry in large population cohorts (Lek 2016). This variant is located within a region that binds BRD7 (Harte 2010). Protein-based in silico analysis, which includes protein predictors and evolutionary conservation, predicts that this variant is probably damaging to protein structure and function, and splicing models are uninformative in their assessment as to whether or not the variant is damaging. Based on currently available evidence, it is unclear whether BRCA1 Glu149Ala is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.\"}"],"clinical_assertion_trait_set_id":"SCV000570422","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2017-04-24","version":"5","trait_set_id":"9460","submission_names":["SUB5098196"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-09-25","assertion_type":"variation to disease","internal_id":"1105529","clinical_assertion_observation_ids":["SCV000570422.0"],"id":"SCV000570422","local_key":"GDX:1080047|Not Provided","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000479398","record_status":"current","submitter_id":"26957"}
{"submission_id":"505720.2016-02-27","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000265873","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}}}","date_created":"2016-03-15","version":"1","submission_names":["Chinese507BC_BRCA"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-01","assertion_type":"variation to disease","internal_id":"498108","clinical_assertion_observation_ids":["SCV000265873.0"],"id":"SCV000265873","local_key":"NM_007294.3:c.446A\u003eC|MedGen:CN221572","interpretation_description":"Uncertain significance","variation_id":"37594","record_status":"current","submitter_id":"505720"}
